追溯分析和去中心化分发,以改善Ah受体研究资产的生命周期
Alex C Veith1, Patrick R Carney1, Aijing Wu2
1McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.
Biochemical pharmacology
|March 21, 2025
概括
这项研究通过对生物样本和模型的元数据进行重新分析和更新,提高了科学研究资产的可共享性. 区块链技术和非真菌代币 (NFT) 用于改善资产跟踪和可访问性.
科学领域:
- * 生物技术和生物医学研究
- * 数据管理和存档
- *科学资产管理科学资产管理
背景情况:
- *科学进步依赖于研究资产的共享,如数据,试剂,模型和样本.
- * 从历史上看,这些资产的可用性和特征性会随着时间的推移而恶化,阻碍其可复制性和进一步的研究.
- * 需要提高先前生成的研究资产的可访问性和实用性.
研究的目的:
- * 评估和增强已建立的研究资产的可共享性,包括重组DNA分子,小鼠模型和组织样本.
- * 实施用于资产表征,本地化和元数据管理的现代技术.
- * 探索区块链和非可变代币 (NFT) 的使用,以确保和跟踪研究资产.
主要方法:
- * 追溯分析十篇出版物,跨越了三十多年的时间,以确定和重新评估研究资产.
- * 应用先进的分子技术来更新复合模型的测序和映射.
- * 实施基于区块链的内部资源,用于标准化元数据和在Solana公共区块链上创建NFT.
主要成果:
- *成功更新了现有研究资产的本地化和分子特征.
- * 证明了先前生成的组织样本的实用性,这些样本通常难以和昂贵地再生.
- *为修订后的元数据建立了去中心化分类账,提高了研究模型的价值和可审计性.
结论:
- *回顾性分析通过更新的特征和位置数据显著改善了可共享的研究资产的范围.
- * 区块链技术为科学资产的描述和代币化提供了一个强大的框架.
- * 这一战略延长了科学资产的寿命和实用性,超出了它们最初的实验室环境.
相关概念视频
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...


